Calcitonin Gene-Related Peptide (CGRP) Antagonists
- Name
- Calcitonin Gene-Related Peptide (CGRP) Antagonists
- Accession Number
- DBCAT004663 (DBCAT005175)
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Erenumab A calcitonin-gene related peptide antagonist used to prevent migraines. Galcanezumab A calcitonin-gene related peptide antagonist used to prevent migraines and treat cluster headaches. Eptinezumab A monoclonal antibody directed against CGRP infused every 3 months for the preventive treatment of migraine in adults. Zavegepant A calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine with or without aura. Fremanezumab A humanized monoclonal antibody directed against human calcitonin-gene related peptide to prevent migraines. Atogepant An oral CGRP antagonist used for the preventative therapy of episodic migraine headaches. Rimegepant An oral CGRP receptor antagonist used for the acute treatment of migraines with or without aura in adults. Ubrogepant An oral CGRP antagonist used in the acute treatment of migraine with or without aura. - Drugs & Drug Targets